Robert Jansen
Urology · Myrtle Beach, SCNPI 1316180847
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,666 of the $17,372 with a category attached, or 72.9%. It is spread thinly across 60 manufacturers, the largest accounting for just 23.5%. Reporting peaked in 2023 at $5,701 and has fallen 67.8% since, to $1,835 in 2025. Among urology clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 526 payments — averaging $33.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$4K
- Teleflex LLC$2K
- EDAP Technomed Inc$1K
- Procept Biorobotics Corporation$905
- Boston Scientific$860
- Myriad Genetic Laboratories, Inc.$831
- plus $8K from 54 others
Across 1 payment — averaging $8000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gyrus ACMI, Inc.$8K
What the payments were for
- Consulting fees$3,50020%
- Travel & lodging$9816%
- Food & beverage$12,66673%
- Education$2251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Porges Coloplast$2,737
- UroLift$756
- AQUABEAM SYSTEM$577
- UroLift System$467
- ZEMDRI (PLAZOMICIN)$380
- Barrigel$335
- Prolaris$306
- TITAN$276
- Axonics$157
- INTERSTIM$156
- Lupron Depot$125
- GENERAL ERECTILE DYSFUNCTION$122
- POSLUMA$121
- UroCuff$114
- rezum Generator$113
How this compares
$17,372 in reported general payments places this provider in the 90th percentile of 196 urology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 121 | $92,677 |
| MyrbetriqMirabegron | 87 | $88,708 |
| XyostedTestosterone Enanthate | 18 | $21,133 |
| Solifenacin Succinate | 258 | $12,864 |
| Testosterone Cypionate | 143 | $8,452 |
| Testosterone | 60 | $6,703 |
| Tamsulosin Hcl | 407 | $6,621 |
| Methenamine Hippurate | 54 | $3,717 |
| Finasteride | 175 | $2,844 |
| Tolterodine Tartrate ErTolterodine Tartrate | 26 | $2,333 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 13 | $1,724 |
| Cephalexin | 99 | $1,412 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 40 | $1,206 |
| Dutasteride | 21 | $1,072 |
| Potassium Citrate ErPotassium Citrate | 11 | $828 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $351 | $92,677121 claims |
| Astellas Pharma US IncMyrbetriq | $391 | $88,70887 claims |
| Antares Pharma, Inc.Xyosted | $501 | $21,13318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 196 urology providers in South Carolina.
Other urology in Myrtle Beach
- Neal ShoreMyrtle Beach$3.2M
- Abhishek SrivastavaMyrtle Beach$41K
- William BogacheMyrtle Beach$41K
- David RichMyrtle Beach$14K
- Richard YoungMyrtle Beach$11K
- Brian RobertsMyrtle Beach$11K
- Manish PatelElgin$213K
- Sandip PrasadCharleston$177K
- Benjamin DropkinGreenville$65K
- Ian MarshallCharleston$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.